{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:44:20Z","timestamp":1790131460393,"version":"4.0.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"DOI":"10.1038\/s43587-024-00740-x","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T11:03:40Z","timestamp":1730459020000},"page":"1512-1515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Lessons from the HEALEY adaptive platform trial in amyotrophic lateral sclerosis"],"prefix":"10.1038","volume":"4","author":[{"given":"Sabrina","family":"Paganoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittney","family":"Harkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7075-1681","authenticated-orcid":false,"given":"Merit","family":"Cudkowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the HEALEY ALS Platform Trial Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"740_CR1","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman, E. L. et al. Lancet 400, 1363\u20131380 (2022).","journal-title":"Lancet"},{"key":"740_CR2","first-page":"e45489","volume":"15","author":"P Hoxhaj","year":"2023","unstructured":"Hoxhaj, P. et al. Cureus 15, e45489 (2023).","journal-title":"Cureus"},{"key":"740_CR3","first-page":"447","volume":"15","author":"A Mullard","year":"2016","unstructured":"Mullard, A. Nat. Rev. Drug Discov. 15, 447 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"740_CR4","doi-asserted-by":"crossref","unstructured":"Yang, X. et al. Antioxidants 10, 1012 (2021).","DOI":"10.3390\/antiox10071012"},{"key":"740_CR5","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41576-023-00592-y","volume":"24","author":"F Ak\u00e7imen","year":"2023","unstructured":"Ak\u00e7imen, F. et al. Nat. Rev. Genet. 24, 642\u2013658 (2023).","journal-title":"Nat. Rev. Genet."},{"key":"740_CR6","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/s41582-023-00891-2","volume":"19","author":"R McMackin","year":"2023","unstructured":"McMackin, R., Bede, P., Ingre, C., Malaspina, A. & Hardiman, O. Nat. Rev. Neurol. 19, 754\u2013768 (2023).","journal-title":"Nat. Rev. Neurol."},{"key":"740_CR7","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","volume":"13","author":"R Mejzini","year":"2019","unstructured":"Mejzini, R. et al. Front. Neurosci. 13, 1310 (2019).","journal-title":"Front. Neurosci."},{"key":"740_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinepi.2020.04.025","volume":"125","author":"JJH Park","year":"2020","unstructured":"Park, J. J. H. et al. J. Clin. Epidemiol. 125, 1\u20138 (2020).","journal-title":"J. Clin. Epidemiol."},{"key":"740_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/NEJMra1510062","volume":"377","author":"J Woodcock","year":"2017","unstructured":"Woodcock, J. & LaVange, L. M. N. Engl. J. Med. 377, 62\u201370 (2017).","journal-title":"N. Engl. J. Med."},{"key":"740_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/ana.26285","volume":"91","author":"S Paganoni","year":"2022","unstructured":"Paganoni, S. et al. Ann. Neurol. 91, 165\u2013175 (2022).","journal-title":"Ann. Neurol."},{"key":"740_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/ana.26714","volume":"94","author":"M Quintana","year":"2023","unstructured":"Quintana, M. et al. Ann. Neurol. 94, 547\u2013560 (2023).","journal-title":"Ann. Neurol."},{"key":"740_CR12","doi-asserted-by":"crossref","unstructured":"The Adaptive Platform Trials Coalition. Nat. Rev. Drug Discov. 18, 797\u2013807 (2019).","DOI":"10.1038\/s41573-019-0034-3"},{"key":"740_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-024-01760-0","volume":"9","author":"X-P Duan","year":"2024","unstructured":"Duan, X.-P. et al. Signal Transduct. Target. Ther. 9, 57 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"740_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fneur.2019.00293","volume":"10","author":"P Lingor","year":"2019","unstructured":"Lingor, P. et al. Front. Neurol. 10, 293 (2019).","journal-title":"Front. Neurol."},{"key":"740_CR15","doi-asserted-by":"publisher","first-page":"1308577","DOI":"10.3389\/fnagi.2024.1308577","volume":"16","author":"AW Wolff","year":"2024","unstructured":"Wolff, A. W. et al. Front. Aging Neurosci. 16, 1308577 (2024).","journal-title":"Front. Aging Neurosci."}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00740-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00740-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00740-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T19:05:23Z","timestamp":1731611123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00740-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":15,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["740"],"URL":"https:\/\/doi.org\/10.1038\/s43587-024-00740-x","relation":{},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"assertion":[{"value":"1 November 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.P. reports research grants from Amylyx Therapeutics, Revalesio Corporation, Alector, Eledon, UCB, Biohaven, Clene Nanomedicine, Prilenia, Seelos, Calico, Denali, NIH, CDC, DoD, The ALS Association, the American Academy of Neurology, ALS Finding a Cure, the Salah Foundation, the Spastic Paraplegia Foundation, the Muscular Dystrophy Association, Tambourine and reports consulting fees from Amylyx, Orion, Medscape, Eikonizo, Prilenia, Clene, PharmAust, Merck, Biogen, Janssen, Arrowhead, and Cytokinetics. M.C. reports consulting fees from Novartis, Roche, Transposon, VectorY, Quralis, Cytokinetics, Regeneron, Pasithea, Inflectis, Servier, Coya and is board member at Praxis. She has received institutional research support from UCB, Biohaven, Clene Nanomedicine, Prilenia, Seelos, Calico, Denali, Coya, ITB, ALSA, MDA, ALS Finding a Cure, ALS One, Arthur Blank Foundation and the NINDS. B.H. and E.G. report no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}